Table 4.
GPA progression rate | CMvD(−), n = 30 | CMvD(+), n = 33 | P value |
---|---|---|---|
RNFL GPA progression rate, µm/yr | |||
Average | −0.39 ± 0.59 | −0.80 ± 0.66 | 0.009* |
Superior quadrant | −0.52 ± 1.02 | −1.18 ± 1.11 | 0.020* |
Inferior quadrant | −1.06 ± 1.19 | −1.45 ± 1.26 | 0.219 |
RNFL progression, n (%)† | 7 (23.3%) | 22 (66.7%) | 0.001* |
GCIPL progression rate, µm/yr | |||
Average | −0.40 ± 0.38 | −0.72 ± 0.51 | 0.009* |
Superior hemifield | −0.38 ± 0.42 | −0.59 ± 0.51 | 0.091 |
Inferior hemifield | −0.44 ± 0.49 | −0.90 ± 0.89 | 0.016* |
GCIPL progression, n (%)† | 3 (10.7%) | 16 (48.5%) | 0.002* |
Data are reported as mean ± standard deviation or n (%). *P < 0.05 by independent t-tests unless otherwise indicated. †Chi-squared tests.
Abbreviations: CMvD, choroidal microvasculature dropout; n, number; RNFL, retinal nerve fiber layer; GCIPL, ganglion cell inner plexiform layer; GPA, guided progression analysis.